Share

July 2022; 9 (4) Comment

Comment: Humoral and T-cell Immunities to SARS-CoV-2 Vaccines: Safety, Efficacy, and Challenges in Autoimmune Neurology

Marinos C. Dalakas, Josep Dalmau
First published June 21, 2022, DOI: https://doi.org/10.1212/NXI.0000000000200010
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
272

Share

Article Information

vol. 9 no. 4 e200010
DOI: 
https://doi.org/10.1212/NXI.0000000000200010
PubMed: 
35728948
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received May 6, 2022
  • Accepted in final form May 6, 2022
  • First Published June 21, 2022.
Copyright & Usage: 
© 2022 American Academy of Neurology

Author Disclosures

    1. Marinos C. Dalakas, MD, FAAN (mdalakas@med.uoa.gr) and
    2. Josep Dalmau, MD, PhD, FAAN
  1. Marinos C. Dalakas, MD, FAAN (mdalakas@med.uoa.gr) and
  2. Josep Dalmau, MD, PhD, FAAN
  1. From the Thomas Jefferson University (M.C.D.), Philadelphia, PA; University of Athens Medical School (M.C.D.), Greece; IDIBAPS-Hospital Clinic of Barcelona (J.D.), University of Barcelona, Spain; Department of Neurology (J.D.), University of Pennsylvania, PA; and Catalan Institution for Research and Advanced Studies (ICREA) (J.D.), Barcelona, Spain.
  1. Correspondence
    marinos.dalakas{at}jefferson.edu or jdalmau{at}clinic.cat
View Full Text

Article usage

Article usage: June 2022 to April 2023

AbstractFullPdfSource
Jun 2022029259Highwire
Jul 2022418254Highwire
Aug 202238942Highwire
Sep 202246610Highwire
Oct 202264617Highwire
Nov 202207321Highwire
Dec 202202914Highwire
Jan 202304313Highwire
Feb 202302915Highwire
Mar 20231169Highwire
Apr 202301918Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me